宫颈上皮内瘤变 2/3 级的临床试验
总计668个结果
-
Ontario Clinical Oncology Group (OCOG)Canadian Institutes of Health Research (CIHR)完全的
-
Northwestern UniversityNational Cancer Institute (NCI); BrainUp Inc尚未招聘
-
Zydolab - Institute of Cytology and Immune CytochemistryRuhr University of Bochum完全的
-
Zydolab - Institute of Cytology and Immune CytochemistryRuhr University of Bochum完全的
-
Zydolab - Institute of Cytology and Immune CytochemistryRuhr University of Bochum完全的
-
Frantz Viral Therapeutics, LLCAnal Dysplasia Clinic MidWest; Laser Surgery Care, LLC招聘中
-
JhpiegoJawaharlal Nehru Medical College完全的
-
Duke UniversityNational Cancer Institute (NCI); Jacobi Medical Center完全的
-
The University of Texas Health Science Center,...撤销
-
National Cancer Institute (NCI)招聘中
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)主动,不招人复发性 1 级滤泡性淋巴瘤 | 复发性 2 级滤泡性淋巴瘤 | 复发性 3 级滤泡性淋巴瘤 | 难治性滤泡性淋巴瘤 | 3a 级滤泡性淋巴瘤美国, 加拿大, 新加坡
-
Antiva Biosciences终止
-
Instituto Nacional de Salud Publica, Mexico完全的
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)终止
-
University of Texas Southwestern Medical Center撤销Cervix Uteri--Diseases
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...完全的
-
AIO-Studien-gGmbHNovartis Pharmaceuticals; Assign Data Management and Biostatistics GmbH完全的神经内分泌癌,3 级 | 低分化恶性神经内分泌癌 | 转为 G3 的 1 级神经内分泌癌 [分化良好的神经内分泌癌] | 转为 G3 的 2 级神经内分泌癌 [中度分化神经内分泌癌] | 神经内分泌肿瘤,3 级和疾病进展,根据实体瘤反应评估标准 (RECIST 1.1.) 衡量德国
-
Sunnybrook Health Sciences CentreMerck Canada Inc.主动,不招人
-
iStat Biomedical CO., Ltd.Mackay Memorial Hospital; Chang Gung Memorial Hospital; Li Shin Hospital未知
-
Skane University HospitalSwedish Cancer Society; Europe Against Cancer (European Union Directorate General XII- Public...完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)完全的